Skip to main content
Log in

Interferon-Induced Anti-HBE Seroconversion Correlates with a Th1 Cytokine Shift Following Emergence of Core Promoter Mutations in Chronic Hepatitis B

  • Letter to the Editor
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bertoletti A, Ferrari C: Kinetics of the immune response during HBV and HCV infection. Hepatology 38:4–13, 2003

    Article  PubMed  Google Scholar 

  2. Penna A, Del Prete G, Cavalli A, Bertoletti A, D'Elios MM, Sorrentino R, D'Amato M, Boni C, Pilli M, Fiaccadori F, Ferrari C: Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis. Hepatology 25:1022–1027, 1997

    Article  PubMed  Google Scholar 

  3. Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naumov NV: Interleukin 12 induction of TH1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 99:3025–3033, 1997

    PubMed  Google Scholar 

  4. Rico MA, Quiroga JA, Subira D, Castanon S, Esteban JM, Pardo M, Carreno V: Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology 33:295–300, 2001

    Article  PubMed  Google Scholar 

  5. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, Tur-Kaspa R, Klein T: Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 98:144–150, 2003

    Article  PubMed  Google Scholar 

  6. Zampino R, Marrone A, Cirillo G, Miraglia del Giudice E, Utili R, Karayiannis P, Liang TJ, Ruggiero G: Sequential analysis of HBV core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment. J Viral Hepat 9:183–188, 2002

    Article  PubMed  Google Scholar 

  7. Marrone A, Zampino R, Luongo G, Utili R, Karayiannis P, Ruggiero G: Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection. Intervirology 46:222–226, 2003

    Article  PubMed  Google Scholar 

  8. Erhardt A, Reineke U, Blondin D Gerlich WH, Adams O, Heintges T, Niederau C, Haussinger D: Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology 31:716–725, 2000

    Article  PubMed  Google Scholar 

  9. Milich DR, Jones JE, Hughes JL, Price J, Rnaey AK, McLachlan A: Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 87:6599–6603, 1990

    PubMed  Google Scholar 

  10. Boni C, Penna A, Ogg GS, Bertoletti A, Pilli M, Cavallo C, Cavalli A, Urbani S, Boehme R, Panebianco R, Fiaccadori F, Ferrari C: Lamivudine can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 33:963–971, 2001

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rosa Zampino MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zampino, R., Mangoni, E.D., Marrone, A. et al. Interferon-Induced Anti-HBE Seroconversion Correlates with a Th1 Cytokine Shift Following Emergence of Core Promoter Mutations in Chronic Hepatitis B. Dig Dis Sci 50, 1791–1792 (2005). https://doi.org/10.1007/s10620-005-2939-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-2939-4

Navigation